v3.26.3
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Shares [Member]
Treasury Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income/(Loss)
Beginning balance at Dec. 31, 2024 $ 1,932,080 $ 2,698 $ (62) $ 3,293,556 $ (1,365,952) $ 1,840
Beginning balance, Shares at Dec. 31, 2024   85,741,981        
Treasury stock, Beginning balance (in shares) at Dec. 31, 2024     170,316      
Issuance of common shares, net of issuance costs 8,637 $ 5   8,632    
Issuance of common shares, net of issuance costs (in shares)   162,482        
Vesting of restricted shares 15 $ 15        
Vesting of restricted shares (in shares)   396,943        
Exercise of vested options, net of issuance costs 1,264 $ 3   1,261    
Exercise of vested options, net of issuance costs (in shares)   39,996        
Purchase of common stock under ESPP 653     653    
Purchase of common stock under ESPP (in shares)   19,522        
Stock-based compensation expense 20,212     20,212    
Other comprehensive income (loss) 2,295         2,295
Net Income (Loss) (135,996)       (135,996)  
Ending balance at Mar. 31, 2025 1,829,160 $ 2,721 $ (62) 3,324,314 (1,501,948) 4,135
Treasury Stock, Ending balance (in shares) at Mar. 31, 2025     170,316      
Ending balance, Shares at Mar. 31, 2025   86,360,924        
Beginning balance at Dec. 31, 2024 1,932,080 $ 2,698 $ (62) 3,293,556 (1,365,952) 1,840
Beginning balance, Shares at Dec. 31, 2024   85,741,981        
Treasury stock, Beginning balance (in shares) at Dec. 31, 2024     170,316      
Net Income (Loss) (450,986)          
Ending balance at Sep. 30, 2025 1,915,982 $ 3,013 $ (60) 3,724,981 (1,816,938) 4,986
Treasury Stock, Ending balance (in shares) at Sep. 30, 2025     125,316      
Ending balance, Shares at Sep. 30, 2025   93,872,794        
Beginning balance at Mar. 31, 2025 1,829,160 $ 2,721 $ (62) 3,324,314 (1,501,948) 4,135
Beginning balance, Shares at Mar. 31, 2025   86,360,924        
Treasury stock, Beginning balance (in shares) at Mar. 31, 2025     170,316      
Issuance of common shares, net of issuance costs 70,605 $ 65   70,540    
Issuance of common shares, net of issuance costs (in shares)   1,842,105        
Vesting of restricted shares 5 $ 5        
Vesting of restricted shares (in shares)   104,941        
Exercise of vested options, net of issuance costs 2,391 $ 3   2,388    
Exercise of vested options, net of issuance costs (in shares)   68,469        
Stock-based compensation expense 17,607     17,607    
Other comprehensive income (loss) (94)         (94)
Net Income (Loss) (208,549)       (208,549)  
Ending balance at Jun. 30, 2025 1,711,125 $ 2,794 $ (62) 3,414,849 (1,710,497) 4,041
Treasury Stock, Ending balance (in shares) at Jun. 30, 2025     170,316      
Ending balance, Shares at Jun. 30, 2025   88,376,439        
Issuance of common shares, net of issuance costs 275,318 $ 198   275,120    
Issuance of common shares, net of issuance costs (in shares)   4,899,409        
Vesting of restricted shares 3 $ 3        
Vesting of restricted shares (in shares)   88,703        
Exercise of vested options, net of issuance costs 17,605 $ 18 $ 2 17,585    
Exercise of vested options, net of issuance costs (in shares)   483,637 (45,000)      
Purchase of common stock under ESPP 823     823    
Purchase of common stock under ESPP (in shares)   24,606        
Stock-based compensation expense 16,604     16,604    
Other comprehensive income (loss) 945         945
Net Income (Loss) (106,441)       (106,441)  
Ending balance at Sep. 30, 2025 1,915,982 $ 3,013 $ (60) 3,724,981 (1,816,938) 4,986
Treasury Stock, Ending balance (in shares) at Sep. 30, 2025     125,316      
Ending balance, Shares at Sep. 30, 2025   93,872,794        
Beginning balance at Dec. 31, 2025 $ 1,921,813 $ 3,087 $ (60) 3,861,516 (1,947,551) 4,821
Beginning balance, Shares at Dec. 31, 2025   95,894,341        
Treasury stock, Beginning balance (in shares) at Dec. 31, 2025 115,316   115,316      
Vesting of restricted shares $ 22 $ 22        
Vesting of restricted shares (in shares)   349,508        
Exercise of vested options, net of issuance costs 5,619 $ 6   5,613    
Exercise of vested options, net of issuance costs (in shares)   130,231        
Purchase of common stock under ESPP 471     471    
Purchase of common stock under ESPP (in shares)   11,426        
Stock-based compensation expense 16,324     16,324    
Other comprehensive income (loss) (6,762)         (6,762)
Net Income (Loss) (122,931)       (122,931)  
Ending balance at Mar. 31, 2026 1,814,556 $ 3,115 $ (60) 3,883,924 (2,070,482) (1,941)
Treasury Stock, Ending balance (in shares) at Mar. 31, 2026     115,316      
Ending balance, Shares at Mar. 31, 2026   96,385,506        
Beginning balance at Dec. 31, 2025 $ 1,921,813 $ 3,087 $ (60) 3,861,516 (1,947,551) 4,821
Beginning balance, Shares at Dec. 31, 2025   95,894,341        
Treasury stock, Beginning balance (in shares) at Dec. 31, 2025 115,316   115,316      
Exercise of vested options, net of issuance costs (in shares) 457,074          
Net Income (Loss) $ (325,522)          
Ending balance at Sep. 30, 2026 $ 1,648,068 $ 3,149 $ (60) 3,932,135 (2,273,073) (14,083)
Treasury Stock, Ending balance (in shares) at Sep. 30, 2026 75,316   75,316      
Ending balance, Shares at Sep. 30, 2026   96,855,526        
Beginning balance at Mar. 31, 2026 $ 1,814,556 $ 3,115 $ (60) 3,883,924 (2,070,482) (1,941)
Beginning balance, Shares at Mar. 31, 2026   96,385,506        
Treasury stock, Beginning balance (in shares) at Mar. 31, 2026     115,316      
Vesting of restricted shares 9 $ 9        
Vesting of restricted shares (in shares)   79,626        
Exercise of vested options, net of issuance costs 8,512 $ 6   8,506    
Exercise of vested options, net of issuance costs (in shares)   195,827 (15,000)      
Stock-based compensation expense 17,316     17,316    
Other comprehensive income (loss) (2,688)         (2,688)
Net Income (Loss) (91,154)       (91,154)  
Ending balance at Jun. 30, 2026 1,746,551 $ 3,130 $ (60) 3,909,746 (2,161,636) (4,629)
Treasury Stock, Ending balance (in shares) at Jun. 30, 2026     100,316      
Ending balance, Shares at Jun. 30, 2026   96,660,959        
Vesting of restricted shares 12 $ 12        
Vesting of restricted shares (in shares)   48,223        
Exercise of vested options, net of issuance costs 3,753 $ 7   3,746    
Exercise of vested options, net of issuance costs (in shares)   131,016 (25,000)      
Purchase of common stock under ESPP 682     682    
Purchase of common stock under ESPP (in shares)   15,328        
Stock-based compensation expense 17,961     17,961    
Other comprehensive income (loss) (9,454)         (9,454)
Net Income (Loss) (111,437)       (111,437)  
Ending balance at Sep. 30, 2026 $ 1,648,068 $ 3,149 $ (60) $ 3,932,135 $ (2,273,073) $ (14,083)
Treasury Stock, Ending balance (in shares) at Sep. 30, 2026 75,316   75,316      
Ending balance, Shares at Sep. 30, 2026   96,855,526